Immune Response News and Research

RSS

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Scientists hypothesize that the GNA affinity resin would remain effective against SARS-CoV-2 variants.

2 Aug 2022

Shear-thinning biomaterial-based minimally invasive strategy for delivery of targeted immunotherapy

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed and optimized a minimally invasive method for more targeted, efficient, and sustained delivery of immunotherapeutic treatments for cancer.

2 Aug 2022

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

The University of Texas MD Anderson Cancer Center and TransCode Therapeutics, Inc. today announced a strategic alliance to advance TransCode's pipeline of RNA-targeted oncology therapeutic and diagnostic candidates.

2 Aug 2022

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

Pediatric adjuvant formulation offers protection against RSV in newborns

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

2 Aug 2022

mRNA vaccines induce faster antibody response against infectious diseases

A new study describes that mRNA vaccines induce antigen-specific antibody response within a very short period of time after immunization.

2 Aug 2022

Novel subset of immune cells confers fast-acting and lasting protection against ischemic stroke

A unique subset of white blood cells confers fast-acting and lasting protection against ischemic stroke in mice, University of Pittsburgh neurologists and immunologists reported in the Journal of Clinical Investigation today.

1 Aug 2022

What is the immunopathogenesis of pediatric COVID-19?

Researchers assessed the immunopathogenesis of COVID-19 infection in children.

1 Aug 2022

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.

31 Jul 2022

Nanoparticles' toxic effects on macrophages

Researchers summarize the toxic effects of nanoparticles on macrophages in vitro.

31 Jul 2022

Is cannabidiol effective against COVID-19?

A new study discusses the utility of CBD in treating the inflammatory symptoms of COVID-19

31 Jul 2022

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

Wake Forest Institute for Regenerative Medicine researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy – immune checkpoint blockage, a promising cancer treatment development – to determine why some patients don't respond or develop a resistance to the treatment over time.

29 Jul 2022

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

The bat-virus relationship examined

A new study examines the role of bats as reservoirs of several viruses and the factors that contribute to the emergence of these viruses.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

In a new study, researchers assessed the antibody response and cellular immunity induced by SARS-CoV-2 Omicron infection in children.

28 Jul 2022

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

Researchers have reviewed the role of cytokine or cellular response and vaginal microbiome dysbiosis in the persistence, clearance, and recurrence of HPV infection

28 Jul 2022

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Immune Response News and Research

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Shear-thinning biomaterial-based minimally invasive strategy for delivery of targeted immunotherapy

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Pediatric adjuvant formulation offers protection against RSV in newborns

mRNA vaccines induce faster antibody response against infectious diseases

Novel subset of immune cells confers fast-acting and lasting protection against ischemic stroke

What is the immunopathogenesis of pediatric COVID-19?

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Nanoparticles' toxic effects on macrophages

Is cannabidiol effective against COVID-19?

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Moderna COVID vaccine is more effective in older and sicker veterans over time

The bat-virus relationship examined

Predicting viral antibody escape using pre-pandemic data

Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News